進行性多巣性白質脳症治療の世界市場（～2026年）

• 英文タイトル：Global Progressive Multifocal Leukoencephalopathy Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04380 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は進行性多巣性白質脳症治療のグローバル市場について調査・分析したレポートです。種類別（抗レトロウイルス療法、抗ウイルス/抗JCV、その他の症状）市場規模、用途別（病院薬局、ドラッグストア、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別進行性多巣性白質脳症治療の競争状況、市場シェア ・世界の進行性多巣性白質脳症治療市場：種類別市場規模 2015年-2020年（抗レトロウイルス療法、抗ウイルス/抗JCV、その他の症状） ・世界の進行性多巣性白質脳症治療市場：種類別市場規模予測 2021年-2026年（抗レトロウイルス療法、抗ウイルス/抗JCV、その他の症状） ・世界の進行性多巣性白質脳症治療市場：用途別市場規模 2015年-2020年（病院薬局、ドラッグストア、小売薬局） ・世界の進行性多巣性白質脳症治療市場：用途別市場規模予測 2021年-2026年（病院薬局、ドラッグストア、小売薬局） ・北米の進行性多巣性白質脳症治療市場分析：米国、カナダ ・ヨーロッパの進行性多巣性白質脳症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの進行性多巣性白質脳症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の進行性多巣性白質脳症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの進行性多巣性白質脳症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Roche、Gilead Sciences、GlaxoSmithKline、Sanofi、Allergan、Novartis、Mylan、AbbVie、Bristol-Myers Squibb ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Progressive multifocal leukoencephalopathy is a rare but debilitating and frequently fatal viral disease of the central nervous system, primarily affecting individuals with chronically and severely suppressed immune systems.
Growing prevalence of HIV is expected to drive the growth of the progressive multifocal leukoencephalopathy treatment market.

Market Analysis and Insights: Global Progressive Multifocal Leukoencephalopathy Treatment Market
The global Progressive Multifocal Leukoencephalopathy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Progressive Multifocal Leukoencephalopathy Treatment Scope and Market Size
Progressive Multifocal Leukoencephalopathy Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Progressive Multifocal Leukoencephalopathy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Roche
Gilead Sciences
GlaxoSmithKline
Sanofi
Allergan
Novartis
Mylan
AbbVie
Bristol-Myers Squibb

Market segment by Type, the product can be split into
Anti-Retroviral Therapy
Antiviral/Anti JCV
Other Symptomatic
Market segment by Application, split into
Hospital Pharmacies
Drug Stores
Retail Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Progressive Multifocal Leukoencephalopathy Treatment Revenue
1.4 Market by Type
1.4.1 Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anti-Retroviral Therapy
1.4.3 Antiviral/Anti JCV
1.4.4 Other Symptomatic
1.5 Market by Application
1.5.1 Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Drug Stores
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Progressive Multifocal Leukoencephalopathy Treatment Market Perspective (2015-2026)
2.2 Global Progressive Multifocal Leukoencephalopathy Treatment Growth Trends by Regions
2.2.1 Progressive Multifocal Leukoencephalopathy Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Progressive Multifocal Leukoencephalopathy Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Progressive Multifocal Leukoencephalopathy Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Progressive Multifocal Leukoencephalopathy Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Progressive Multifocal Leukoencephalopathy Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Progressive Multifocal Leukoencephalopathy Treatment Players by Market Size
3.1.1 Global Top Progressive Multifocal Leukoencephalopathy Treatment Players by Revenue (2015-2020)
3.1.2 Global Progressive Multifocal Leukoencephalopathy Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Progressive Multifocal Leukoencephalopathy Treatment Market Concentration Ratio
3.2.1 Global Progressive Multifocal Leukoencephalopathy Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Progressive Multifocal Leukoencephalopathy Treatment Revenue in 2019
3.3 Progressive Multifocal Leukoencephalopathy Treatment Key Players Head office and Area Served
3.4 Key Players Progressive Multifocal Leukoencephalopathy Treatment Product Solution and Service
3.5 Date of Enter into Progressive Multifocal Leukoencephalopathy Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Progressive Multifocal Leukoencephalopathy Treatment Historic Market Size by Type (2015-2020)
4.2 Global Progressive Multifocal Leukoencephalopathy Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2015-2020)
5.2 Global Progressive Multifocal Leukoencephalopathy Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Progressive Multifocal Leukoencephalopathy Treatment Market Size (2015-2020)
6.2 Progressive Multifocal Leukoencephalopathy Treatment Key Players in North America (2019-2020)
6.3 North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2015-2020)
6.4 North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size (2015-2020)
7.2 Progressive Multifocal Leukoencephalopathy Treatment Key Players in Europe (2019-2020)
7.3 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2015-2020)
7.4 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2015-2020)

8 China
8.1 China Progressive Multifocal Leukoencephalopathy Treatment Market Size (2015-2020)
8.2 Progressive Multifocal Leukoencephalopathy Treatment Key Players in China (2019-2020)
8.3 China Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2015-2020)
8.4 China Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Progressive Multifocal Leukoencephalopathy Treatment Market Size (2015-2020)
9.2 Progressive Multifocal Leukoencephalopathy Treatment Key Players in Japan (2019-2020)
9.3 Japan Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2015-2020)
9.4 Japan Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Size (2015-2020)
10.2 Progressive Multifocal Leukoencephalopathy Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2015-2020)

11 India
11.1 India Progressive Multifocal Leukoencephalopathy Treatment Market Size (2015-2020)
11.2 Progressive Multifocal Leukoencephalopathy Treatment Key Players in India (2019-2020)
11.3 India Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2015-2020)
11.4 India Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Progressive Multifocal Leukoencephalopathy Treatment Market Size (2015-2020)
12.2 Progressive Multifocal Leukoencephalopathy Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2015-2020)
12.4 Central & South America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Progressive Multifocal Leukoencephalopathy Treatment Introduction
13.1.4 Pfizer Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche Progressive Multifocal Leukoencephalopathy Treatment Introduction
13.2.4 Roche Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Gilead Sciences
13.3.1 Gilead Sciences Company Details
13.3.2 Gilead Sciences Business Overview
13.3.3 Gilead Sciences Progressive Multifocal Leukoencephalopathy Treatment Introduction
13.3.4 Gilead Sciences Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020)
13.3.5 Gilead Sciences Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Progressive Multifocal Leukoencephalopathy Treatment Introduction
13.4.4 GlaxoSmithKline Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview
13.5.3 Sanofi Progressive Multifocal Leukoencephalopathy Treatment Introduction
13.5.4 Sanofi Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020)
13.5.5 Sanofi Recent Development
13.6 Allergan
13.6.1 Allergan Company Details
13.6.2 Allergan Business Overview
13.6.3 Allergan Progressive Multifocal Leukoencephalopathy Treatment Introduction
13.6.4 Allergan Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020)
13.6.5 Allergan Recent Development
13.7 Novartis
13.7.1 Novartis Company Details
13.7.2 Novartis Business Overview
13.7.3 Novartis Progressive Multifocal Leukoencephalopathy Treatment Introduction
13.7.4 Novartis Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020)
13.7.5 Novartis Recent Development
13.8 Mylan
13.8.1 Mylan Company Details
13.8.2 Mylan Business Overview
13.8.3 Mylan Progressive Multifocal Leukoencephalopathy Treatment Introduction
13.8.4 Mylan Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020)
13.8.5 Mylan Recent Development
13.9 AbbVie
13.9.1 AbbVie Company Details
13.9.2 AbbVie Business Overview
13.9.3 AbbVie Progressive Multifocal Leukoencephalopathy Treatment Introduction
13.9.4 AbbVie Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020)
13.9.5 AbbVie Recent Development
13.10 Bristol-Myers Squibb
13.10.1 Bristol-Myers Squibb Company Details
13.10.2 Bristol-Myers Squibb Business Overview
13.10.3 Bristol-Myers Squibb Progressive Multifocal Leukoencephalopathy Treatment Introduction
13.10.4 Bristol-Myers Squibb Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020)
13.10.5 Bristol-Myers Squibb Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Progressive Multifocal Leukoencephalopathy Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Progressive Multifocal Leukoencephalopathy Treatment Revenue
Table 3. Ranking of Global Top Progressive Multifocal Leukoencephalopathy Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anti-Retroviral Therapy
Table 6. Key Players of Antiviral/Anti JCV
Table 7. Key Players of Other Symptomatic
Table 8. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Regions (2015-2020)
Table 12. Global Progressive Multifocal Leukoencephalopathy Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Progressive Multifocal Leukoencephalopathy Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Progressive Multifocal Leukoencephalopathy Treatment Players
Table 19. Global Progressive Multifocal Leukoencephalopathy Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Players (2015-2020)
Table 21. Global Top Progressive Multifocal Leukoencephalopathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Progressive Multifocal Leukoencephalopathy Treatment as of 2019)
Table 22. Global Progressive Multifocal Leukoencephalopathy Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Progressive Multifocal Leukoencephalopathy Treatment Product Solution and Service
Table 25. Date of Enter into Progressive Multifocal Leukoencephalopathy Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Share by Type (2015-2020)
Table 29. Global Progressive Multifocal Leukoencephalopathy Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Share by Application (2015-2020)
Table 31. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Progressive Multifocal Leukoencephalopathy Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Progressive Multifocal Leukoencephalopathy Treatment Market Share (2019-2020)
Table 35. North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2015-2020)
Table 37. North America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Progressive Multifocal Leukoencephalopathy Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Progressive Multifocal Leukoencephalopathy Treatment Market Share (2019-2020)
Table 41. Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2015-2020)
Table 43. Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Progressive Multifocal Leukoencephalopathy Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Progressive Multifocal Leukoencephalopathy Treatment Market Share (2019-2020)
Table 47. China Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2015-2020)
Table 49. China Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Progressive Multifocal Leukoencephalopathy Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Progressive Multifocal Leukoencephalopathy Treatment Market Share (2019-2020)
Table 53. Japan Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2015-2020)
Table 55. Japan Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Progressive Multifocal Leukoencephalopathy Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Progressive Multifocal Leukoencephalopathy Treatment Market Share (2019-2020)
Table 59. Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Progressive Multifocal Leukoencephalopathy Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Progressive Multifocal Leukoencephalopathy Treatment Market Share (2019-2020)
Table 65. India Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2015-2020)
Table 67. India Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Progressive Multifocal Leukoencephalopathy Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Progressive Multifocal Leukoencephalopathy Treatment Market Share (2019-2020)
Table 71. Central & South America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2015-2020)
Table 75. Pfizer Company Details
Table 76. Pfizer Business Overview
Table 77. Pfizer Product
Table 78. Pfizer Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020) (Million US$)
Table 79. Pfizer Recent Development
Table 80. Roche Company Details
Table 81. Roche Business Overview
Table 82. Roche Product
Table 83. Roche Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020) (Million US$)
Table 84. Roche Recent Development
Table 85. Gilead Sciences Company Details
Table 86. Gilead Sciences Business Overview
Table 87. Gilead Sciences Product
Table 88. Gilead Sciences Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020) (Million US$)
Table 89. Gilead Sciences Recent Development
Table 90. GlaxoSmithKline Company Details
Table 91. GlaxoSmithKline Business Overview
Table 92. GlaxoSmithKline Product
Table 93. GlaxoSmithKline Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020) (Million US$)
Table 94. GlaxoSmithKline Recent Development
Table 95. Sanofi Company Details
Table 96. Sanofi Business Overview
Table 97. Sanofi Product
Table 98. Sanofi Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020) (Million US$)
Table 99. Sanofi Recent Development
Table 100. Allergan Company Details
Table 101. Allergan Business Overview
Table 102. Allergan Product
Table 103. Allergan Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020) (Million US$)
Table 104. Allergan Recent Development
Table 105. Novartis Company Details
Table 106. Novartis Business Overview
Table 107. Novartis Product
Table 108. Novartis Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020) (Million US$)
Table 109. Novartis Recent Development
Table 110. Mylan Business Overview
Table 111. Mylan Product
Table 112. Mylan Company Details
Table 113. Mylan Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020) (Million US$)
Table 114. Mylan Recent Development
Table 115. AbbVie Company Details
Table 116. AbbVie Business Overview
Table 117. AbbVie Product
Table 118. AbbVie Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020) (Million US$)
Table 119. AbbVie Recent Development
Table 120. Bristol-Myers Squibb Company Details
Table 121. Bristol-Myers Squibb Business Overview
Table 122. Bristol-Myers Squibb Product
Table 123. Bristol-Myers Squibb Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2015-2020) (Million US$)
Table 124. Bristol-Myers Squibb Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type: 2020 VS 2026
Figure 2. Anti-Retroviral Therapy Features
Figure 3. Antiviral/Anti JCV Features
Figure 4. Other Symptomatic Features
Figure 5. Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Drug Stores Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Progressive Multifocal Leukoencephalopathy Treatment Report Years Considered
Figure 10. Global Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Players in 2019
Figure 15. Global Top Progressive Multifocal Leukoencephalopathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Progressive Multifocal Leukoencephalopathy Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Progressive Multifocal Leukoencephalopathy Treatment Revenue in 2019
Figure 17. North America Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Progressive Multifocal Leukoencephalopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

---